OnKure Therapeutics, Inc. SEC filings OKUR
OnKure Therapeutics, Inc. has 404 filings in SEC EDGAR's recent list, going back to Jan 8, 2018. Its latest annual report, Form ARS, was filed on Apr 21, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Aug 4, 2026 | — |
| S-8 | Employee stock plan registration | Jun 5, 2026 | — |
| S-3 | Shelf registration | Apr 24, 2026 | — |
| S-8 | Employee stock plan registration | Mar 12, 2026 | — |
| 424B3 | Prospectus | Nov 21, 2025 | — |
| POS AM | Filing | Nov 6, 2025 | — |
| S-3 | Shelf registration | Nov 6, 2025 | — |
| 424B3 | Prospectus | Nov 6, 2025 | — |
| 424B3 | Prospectus | Aug 12, 2025 | — |
| 424B3 | Prospectus | May 28, 2025 | — |
| 424B3 | Prospectus | May 6, 2025 | — |
| 424B3 | Prospectus | Mar 24, 2025 | — |
| POS AM | Filing | Mar 20, 2025 | — |
| S-8 | Employee stock plan registration | Mar 10, 2025 | — |
| 424B3 | Prospectus | Mar 10, 2025 | — |
| 424B3 | Prospectus | Dec 10, 2024 | — |
| S-8 | Employee stock plan registration | Dec 9, 2024 | — |
| 424B3 | Prospectus | Nov 7, 2024 | — |
| 424B3 | Prospectus | Oct 31, 2024 | — |
| S-1 | Registration statement | Oct 23, 2024 | — |
| 424B3 | Prospectus | Aug 26, 2024 | — |
| S-4/A | Filing | Aug 26, 2024 | — |
| S-4/A | Filing | Aug 19, 2024 | — |
| S-4/A | Filing | Jul 29, 2024 | — |
| S-4 | Registration for a merger or exchange | Jun 21, 2024 | — |
| S-8 | Employee stock plan registration | Mar 28, 2024 | — |
| S-3 | Shelf registration | Nov 13, 2023 | — |
| 424B5 | Prospectus supplement | Nov 13, 2023 | — |
| S-3 | Shelf registration | Jun 5, 2023 | — |
| 424B5 | Prospectus supplement | May 4, 2023 | — |
| 424B5 | Prospectus supplement | May 3, 2023 | — |
| S-8 | Employee stock plan registration | Mar 27, 2023 | — |
| S-3 | Shelf registration | May 2, 2022 | — |
| S-8 | Employee stock plan registration | Mar 23, 2022 | — |
| 424B4 | Prospectus | Apr 9, 2021 | — |
| S-8 | Employee stock plan registration | Apr 9, 2021 | — |
| S-1/A | Amended registration statement | Apr 5, 2021 | — |
| S-1 | Registration statement | Mar 19, 2021 | — |
Showing 38 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- OKUR (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Boulder, CO
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1637715
- Former names
- Reneo Pharmaceuticals, Inc. (until Oct 2, 2024)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.